<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37796126</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Ubiquitin E3 ligase SPOP is a host negative regulator of enterovirus 71-encoded 2A protease.</ArticleTitle><Pagination><StartPage>e0078623</StartPage><MedlinePgn>e0078623</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00786-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00786-23</ELocationID><Abstract><AbstractText>EV71 poses a significant health threat to children aged 5 and below. The process of EV71 infection and replication is predominantly influenced by ubiquitination modifications. Our previous findings indicate that EV71 prompts the activation of host deubiquitinating enzymes, thereby impeding the host interferon signaling pathway as a means of evading the immune response. Nevertheless, the precise mechanisms by which the host employs ubiquitination modifications to hinder EV71 infection remain unclear. The present study demonstrated that the nonstructural protein 2A<sup>pro</sup>, which is encoded by EV71, exhibits ubiquitination and degradation mediated by the host E3 ubiquitin ligase SPOP. In addition, it is the first report, to our knowledge, that SPOP is involved in the host antiviral response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zang</LastName><ForeName>Lichao</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0006-3906-9277</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital of Ningbo University, Ningbo First Hospital , Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yukang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiangjie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wenxin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Mengyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ziwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jinhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jingting</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Hui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4325-4946</Identifier><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Soochow University , Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University , Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82102473</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509761">SPOP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="Y">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="Y">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="Y">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="Y">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="Y">Host Microbial Interactions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A protease</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">SPOP</Keyword><Keyword MajorTopicYN="N">ubiquitination</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>10</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37796126</ArticleId><ArticleId IdType="pmc">PMC10617436</ArticleId><ArticleId IdType="doi">10.1128/jvi.00786-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778–790. doi:10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Zhang N, Chen Y, Yin J, Xu M, Cheng X, Ma R, Meng J, Du Y. 2022. Role of non-coding RNA in neurological complications associated with enterovirus 71. Front Cell Infect Microbiol 12:873304. doi:10.3389/fcimb.2022.873304</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.873304</ArticleId><ArticleId IdType="pmc">PMC9081983</ArticleId><ArticleId IdType="pubmed">35548469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang L, Gu J, Yang X, Yuan Y, Guo H, Zhou W, Ma J, Chen Y, Wu Y, Zheng H, Shi W. 2023. Ubiquitin-specific protease 24 promotes Ev71 infection by restricting K63-linked polyubiquitination of Tbk1. Virol Sin 38:75–83. doi:10.1016/j.virs.2022.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC10006192</ArticleId><ArticleId IdType="pubmed">36334706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Shi W, Zhang L, Hu Z, Xu C. 2017. USP19 suppresses cellular type I interferon signaling by targeting TRAF3 for deubiquitination. Future Microbiol 12:767–779. doi:10.2217/fmb-2017-0006</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2017-0006</ArticleId><ArticleId IdType="pubmed">28391724</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Liu J, Lu N, Zhang C. 2021. Enterovirus 71 antagonizes antiviral effects of type III interferon and evades the clearance of intestinal intraepithelial lymphocytes. Front. Microbiol 12:806084. doi:10.3389/fmicb.2021.806084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.806084</ArticleId><ArticleId IdType="pmc">PMC8848745</ArticleId><ArticleId IdType="pubmed">35185830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S, Xu Z, Liu P, Qin Y, Chen M. 2021. Enterovirus 71 2A protease inhibits P-body formation to promote viral RNA synthesis. J Virol 95:e0092221. doi:10.1128/JVI.00922-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00922-21</ArticleId><ArticleId IdType="pmc">PMC8428400</ArticleId><ArticleId IdType="pubmed">34287048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ML, Wu CH, Chien KY, Lai CH, Li GJ, Liu YY, Lin G, Ho HY. 2022. Enteroviral 2B interacts with VDAC3 to regulate reactive oxygen species generation that is essential to viral replication. Viruses 14:1717. doi:10.3390/v14081717</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081717</ArticleId><ArticleId IdType="pmc">PMC9416218</ArticleId><ArticleId IdType="pubmed">36016340</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zheng Z, Liu Y, Zhang Z, Liu Q, Meng J, Ke X, Hu Q, Wang H. 2016. 2C proteins of enteroviruses suppress IKKβ phosphorylation by recruiting protein phosphatase 1. J Virol 90:5141–5151. doi:10.1128/JVI.03021-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03021-15</ArticleId><ArticleId IdType="pmc">PMC4859720</ArticleId><ArticleId IdType="pubmed">26962213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Z, Liang Y, Chen Z, Yin J, Li C, Pan P, Zhang Q, Wu J, Luo Z. 2022. Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to boost exosome biogenesis to facilitate viral replication. Front Microbiol 13:1024899. doi:10.3389/fmicb.2022.1024899</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1024899</ArticleId><ArticleId IdType="pmc">PMC9581156</ArticleId><ArticleId IdType="pubmed">36274707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Chen CJ, Wang RYL, Huang HI, Lin YH, Tam EH, Tu WJ, Wu SE, Shih SR. 2019. Role of enteroviral RNA-dependent RNA polymerase in regulation of Mda5-mediated beta interferon activation. J Virol 93:e00132-19. doi:10.1128/JVI.00132-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00132-19</ArticleId><ArticleId IdType="pmc">PMC6498057</ArticleId><ArticleId IdType="pubmed">30814289</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Yao Y, Chen Y, Zhang S, Deng Z, Qiao W, Tan J. 2022. TRAF3IP3 is cleaved by Ev71 3C protease and exhibits antiviral activity. Front. Microbiol 13:914971. doi:10.3389/fmicb.2022.914971</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.914971</ArticleId><ArticleId IdType="pmc">PMC9260427</ArticleId><ArticleId IdType="pubmed">35814660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LC, Chen SO, Chang SP, Lee YP, Yu CK, Chen CL, Tseng PC, Hsieh CY, Chen SH, Lin CF. 2015. Enterovirus 71 proteins 2A and 3d antagonize the antiviral activity of gamma interferon via signaling attenuation. J Virol 89:7028–7037. doi:10.1128/JVI.00205-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00205-15</ArticleId><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B, Zhou X, Tian L, Wang J, Zhang W. 2022. IFN-β 1b induces OAS3 to inhibit EV71 via IFN-β 1b/JAK/STAT1 pathway. Virol Sin 37:676–684. doi:10.1016/j.virs.2022.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.07.013</ArticleId><ArticleId IdType="pmc">PMC9583119</ArticleId><ArticleId IdType="pubmed">35934228</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Cheng M, Liu B, Yuan M, Chen D, Wang Y, Wu Z. 2021. DEAD-box helicase DDX6 facilitated RIG-I-mediated type-I interferon response to EV71 infection. Front Cell Infect Microbiol 11:725392. doi:10.3389/fcimb.2021.725392</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.725392</ArticleId><ArticleId IdType="pmc">PMC8414799</ArticleId><ArticleId IdType="pubmed">34485180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullmer W, Semler BL. 2018. Direct and indirect effects on viral translation and RNA replication are required for AUF1 restriction of enterovirus infections in human cells. mBio 9:e01669-18. doi:10.1128/mBio.01669-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01669-18</ArticleId><ArticleId IdType="pmc">PMC6123441</ArticleId><ArticleId IdType="pubmed">30181254</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195–205. doi:10.1016/0168-1702(95)00087-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. doi:10.1126/science.1218713</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91–107. doi:10.1111/j.1574-6976.2002.tb00601.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Qiao Q, Hao SB, Dong Z, Zhao L, Ji J, Wang ZY, Wen HL. 2018. Nonstructural protein 2A modulates replication and virulence of enterovirus 71. Virus Res 244:262–269. doi:10.1016/j.virusres.2017.11.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.11.023</ArticleId><ArticleId IdType="pubmed">29175108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Z, Wang B, Zhang X, Gao X, Qin B, Zhao Z, Cui S. 2013. Crystal structure of 2A proteinase from hand, foot and mouth disease virus. J Mol Biol 425:4530–4543. doi:10.1016/j.jmb.2013.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.08.016</ArticleId><ArticleId IdType="pubmed">23973886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Hu Z, Fan S, Zhang Q, Zhong Y, Guo D, Qin Y, Chen M, Sarnow P. 2018. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation. PLoS Pathog 14:e1006901. doi:10.1371/journal.ppat.1006901</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006901</ArticleId><ArticleId IdType="pmc">PMC5819834</ArticleId><ArticleId IdType="pubmed">29415027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WF, Huang RT, Chien KY, Huang JY, Lau KS, Jheng JR, Chiu CH, Wu TY, Chen CY, Horng JT, López S. 2016. Host microRNA miR-197 plays a negative regulatory role in the enterovirus 71 infectious cycle by targeting the RAN protein. J Virol 90:1424–1438. doi:10.1128/JVI.02143-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02143-15</ArticleId><ArticleId IdType="pmc">PMC4719623</ArticleId><ArticleId IdType="pubmed">26581983</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Wang Y, Fu X, Bai G, Li X, Mao J, Yan Y, Hu L. 2023. Multiple functions of stress granules in viral infection at a glance. Front Microbiol 14:1138864. doi:10.3389/fmicb.2023.1138864</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1138864</ArticleId><ArticleId IdType="pmc">PMC10014870</ArticleId><ArticleId IdType="pubmed">36937261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Hu Z, Zhang Q, Fan S, Zhong Y, Guo D, Qin Y, Chen M. 2019. SG formation relies on eIF4Gi-G3BP interaction which is targeted by picornavirus stress antagonists. Cell Discov 5:1. doi:10.1038/s41421-018-0068-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-018-0068-4</ArticleId><ArticleId IdType="pmc">PMC6312541</ArticleId><ArticleId IdType="pubmed">30603102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z, Coyne CB. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. doi:10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86:3767–3776. doi:10.1128/JVI.06687-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C, Hu K, Xi C, Li N, Wei Y. 2019. Transcriptomic analysis of cells in response to EV71 infection and 2A(pro) as a trigger for apoptosis via TXNIP gene. Genes Genomics 41:343–357. doi:10.1007/s13258-018-0760-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13258-018-0760-7</ArticleId><ArticleId IdType="pubmed">30499052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai Y, Kojima T, Muro Y, Hachiya T, Nishizawa Y, Wakabayashi T, Hagiwara M. 1997. Identification of a novel nuclear speckle-type protein, SPOP. FEBS Lett 418:23–26. doi:10.1016/s0014-5793(97)01340-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(97)01340-9</ArticleId><ArticleId IdType="pubmed">9414087</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Xu Y, Pan C, Yan L, Wang ZW, Zhu X. 2020. The emerging role of SPOP protein in tumorigenesis and cancer therapy. Mol Cancer 19:2. doi:10.1186/s12943-019-1124-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-019-1124-x</ArticleId><ArticleId IdType="pmc">PMC6942384</ArticleId><ArticleId IdType="pubmed">31901237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C, Tang YD, Zhai J, Zheng C. 2022. The RING finger protein family in health and disease. Signal Transduct Target Ther 7:300. doi:10.1038/s41392-022-01152-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01152-2</ArticleId><ArticleId IdType="pmc">PMC9424811</ArticleId><ArticleId IdType="pubmed">36042206</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang T, Li J, Liu X, Shi B, Li S, An HX. 2022. An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases. Front. Immunol 13:968777. doi:10.3389/fimmu.2022.968777</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.968777</ArticleId><ArticleId IdType="pmc">PMC9434121</ArticleId><ArticleId IdType="pubmed">36059474</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang F, Wang Q, Zhang N, Zheng J, Zheng M, Liu R, Cui H, Wen J, Zhao G, Luo ZQ. 2020. SPOP promotes ubiquitination and degradation of MyD88 to suppress the innate immune response. PLoS Pathog 16:e1008188. doi:10.1371/journal.ppat.1008188</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008188</ArticleId><ArticleId IdType="pmc">PMC7224567</ArticleId><ArticleId IdType="pubmed">32365080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuneo MJ, O’Flynn BG, Lo YH, Sabri N, Mittag T. 2023. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation. Mol Cell 83:731–745. doi:10.1016/j.molcel.2022.12.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.12.033</ArticleId><ArticleId IdType="pmc">PMC9992347</ArticleId><ArticleId IdType="pubmed">36693379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XM, Wu HL, Xia QD, Zhou P, Wang SG, Yu X, Hu J. 2022. Novel insights into the SPOP E3 ubiquitin ligase: from the regulation of molecular mechanisms to tumorigenesis. Biomed Pharmacother 149:112882. doi:10.1016/j.biopha.2022.112882</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112882</ArticleId><ArticleId IdType="pubmed">35364375</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa M, Higashiyama S. 2020. The roles of SPOP in DNA damage response and DNA replication. Int J Mol Sci 21:7293. doi:10.3390/ijms21197293</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197293</ArticleId><ArticleId IdType="pmc">PMC7582541</ArticleId><ArticleId IdType="pubmed">33023230</ArticleId></ArticleIdList></Reference><Reference><Citation>Swami U, Graf RP, Nussenzveig RH, Fisher V, Tukachinsky H, Schrock AB, Li G, Ross JS, Sayegh N, Tripathi N, Mathew Thomas V, Oxnard GR, Antonarakis ES, Agarwal N. 2022. SPOP mutations as a predictive biomarker for androgen receptor axis-targeted therapy in De Novo metastatic castration-sensitive prostate cancer. Clin Cancer Res 28:4917–4925. doi:10.1158/1078-0432.CCR-22-2228</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-22-2228</ArticleId><ArticleId IdType="pubmed">36088616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M, Qian M, Ruan Z. 2022. CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein. J Immunother Cancer 10:e005270. doi:10.1136/jitc-2022-005270</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2022-005270</ArticleId><ArticleId IdType="pmc">PMC9535172</ArticleId><ArticleId IdType="pubmed">36198437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Lin M, Chu M, Liu Y, Ma J, He Y, Wang Z. 2020. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. EBioMedicine 56:102795. doi:10.1016/j.ebiom.2020.102795</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102795</ArticleId><ArticleId IdType="pmc">PMC7248661</ArticleId><ArticleId IdType="pubmed">32460168</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawaratsumida K, Redecke V, Wu R, Kuriakose J, Bouchard JJ, Mittag T, Lohman BK, Mishra A, High AA, Häcker H. 2022. A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity. Sci Adv 8:eabq0084. doi:10.1126/sciadv.abq0084</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abq0084</ArticleId><ArticleId IdType="pmc">PMC9269885</ArticleId><ArticleId IdType="pubmed">35857476</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillamot M, Ouazia D, Dolgalev I, Yeung ST, Kourtis N, Dai Y, Corrigan K, Zea-Redondo L, Saraf A, Florens L, Washburn MP, Tikhonova AN, Malumbres M, Gong Y, Tsirigos A, Park C, Barbieri C, Khanna KM, Busino L, Aifantis I. 2019. The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation. Nat Immunol 20:1196–1207. doi:10.1038/s41590-019-0454-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0454-6</ArticleId><ArticleId IdType="pmc">PMC7376385</ArticleId><ArticleId IdType="pubmed">31406379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YH, Wang Y, Wang F, Dong YM, Jiang WL, Wang YP, Zhong X, Ma LX. 2021. SPOP negatively regulates toll-like receptor-induced inflammation by disrupting MyD88 self-association. Cell Mol Immunol 18:1708–1717. doi:10.1038/s41423-020-0411-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0411-1</ArticleId><ArticleId IdType="pmc">PMC8245473</ArticleId><ArticleId IdType="pubmed">32235916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Ma J, Wang D, Lin D, Pang X, Wang S, Zhao Y, Shi L, Xue H, Pan Y, Zhang J, Wahlestedt C, Giles FJ, Chen Y, Gleave ME, Collins CC, Ye D, Wang Y, Huang H. 2019. The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer. EMBO Mol Med 11:e10659. doi:10.15252/emmm.201910659</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910659</ArticleId><ArticleId IdType="pmc">PMC6835201</ArticleId><ArticleId IdType="pubmed">31559706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang M, Calabrese MF, Liu J, Waddell MB, Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, Hoggard T, Harper JW, White KP, Schulman BA. 2009. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell 36:39–50. doi:10.1016/j.molcel.2009.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.09.022</ArticleId><ArticleId IdType="pmc">PMC2847577</ArticleId><ArticleId IdType="pubmed">19818708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa M, Fang M, H Marshall C, Lotan TL, Isaacsson Velho P, Antonarakis ES. 2022. Clinical and genomic features of SPOP-mutant prostate cancer. Prostate 82:260–268. doi:10.1002/pros.24269</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pros.24269</ArticleId><ArticleId IdType="pmc">PMC8688331</ArticleId><ArticleId IdType="pubmed">34783071</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Gan W, Li X, Wang S, Zhang W, Huang L, Liu S, Zhong Q, Guo J, Zhang J, Chen T, Shimizu K, Beca F, Blattner M, Vasudevan D, Buckley DL, Qi J, Buser L, Liu P, Inuzuka H, Beck AH, Wang L, Wild PJ, Garraway LA, Rubin MA, Barbieri CE, Wong K-K, Muthuswamy SK, Huang J, Chen Y, Bradner JE, Wei W. 2017. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat Med 23:1063–1071. doi:10.1038/nm.4378</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4378</ArticleId><ArticleId IdType="pmc">PMC5625299</ArticleId><ArticleId IdType="pubmed">28805820</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y, Du Q, Zhang HG, Yuan Y, Zuo Y, Zheng H. 2023. Cycloheximide (CHX) chase assay to examine protein half-life. Bio Protoc 13:e4690. doi:10.21769/BioProtoc.4690</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.4690</ArticleId><ArticleId IdType="pmc">PMC10262206</ArticleId><ArticleId IdType="pubmed">37323633</ArticleId></ArticleIdList></Reference><Reference><Citation>Harhouri K, Navarro C, Depetris D, Mattei M-G, Nissan X, Cau P, De Sandre-Giovannoli A, Lévy N. 2017. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol Med 9:1294–1313. doi:10.15252/emmm.201607315</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607315</ArticleId><ArticleId IdType="pmc">PMC5582415</ArticleId><ArticleId IdType="pubmed">28674081</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao MV, Darji S, Stavrides PH, Goulbourne CN, Kumar A, Yang DS, Yoo L, Peddy J, Lee JH, Yuan A, Nixon RA. 2023. Autophagy is a novel pathway for neurofilament protein degradation in vivo Autophagy 19:1277–1292. doi:10.1080/15548627.2022.2124500</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2124500</ArticleId><ArticleId IdType="pmc">PMC10012948</ArticleId><ArticleId IdType="pubmed">36131358</ArticleId></ArticleIdList></Reference><Reference><Citation>Grice GL, Nathan JA. 2016. The recognition of ubiquitinated proteins by the proteasome. Cell Mol Life Sci 73:3497–3506. doi:10.1007/s00018-016-2255-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2255-5</ArticleId><ArticleId IdType="pmc">PMC4980412</ArticleId><ArticleId IdType="pubmed">27137187</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Gan W, Su S, Hauenstein AV, Fu TM, Brasher B, Schwerdtfeger C, Liang AC, Xu M, Wei W. 2018. K63-linked polyubiquitin chains bind to DNA to facilitate DNA damage repair. Sci Signal 11:eaar8133. doi:10.1126/scisignal.aar8133</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aar8133</ArticleId><ArticleId IdType="pmc">PMC6434707</ArticleId><ArticleId IdType="pubmed">29871913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chathuranga K, Weerawardhana A, Dodantenna N, Lee JS. 2021. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp Mol Med 53:1647–1668. doi:10.1038/s12276-021-00691-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00691-y</ArticleId><ArticleId IdType="pmc">PMC8592830</ArticleId><ArticleId IdType="pubmed">34782737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Li X, Cai X, Zha H, Zhou Z, Sun X, Rong F, Tang J, Zhu C, Liu X, Fan S, Wang J, Liao Q, Ouyang G, Xiao W. 2021. Arginine monomethylation by PRMT7 controls MAVS-mediated antiviral innate immunity. Mol Cell 81:3171–3186. doi:10.1016/j.molcel.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.06.004</ArticleId><ArticleId IdType="pubmed">34171297</ArticleId></ArticleIdList></Reference><Reference><Citation>Au-Yeung N, Horvath CM. 2018. Transcriptional and chromatin regulation in interferon and innate antiviral gene expression. Cytokine Growth Factor Rev 44:11–17. doi:10.1016/j.cytogfr.2018.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC6281172</ArticleId><ArticleId IdType="pubmed">30509403</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng J, Yao Z, He Y, Zhang R, Zhang Y, Yao X, Yang H, Chen L, Zhang Z, Zhang H, Bao X, Hu G, Wu T, Cheng J. 2017. ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65. Cell Death Dis 8:e2866. doi:10.1038/cddis.2017.257</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.257</ArticleId><ArticleId IdType="pmc">PMC5520913</ArticleId><ArticleId IdType="pubmed">28594402</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Peng Y, Zhang Q, Xu XP, Kong XM, Shi WF. 2018. UUSP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication. Sci Rep 8:13418. doi:10.1038/s41598-018-31734-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31734-6</ArticleId><ArticleId IdType="pmc">PMC6128947</ArticleId><ArticleId IdType="pubmed">30194441</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Yang W, Ren J, Ru Y, Zhang K, Fu S, Liu X, Zheng H. 2019. The E3 ubiquitin ligase Tbk1 mediates the degradation of multiple picornavirus VP3 proteins by phosphorylation and ubiquitination. J Virol 93:e01438-19. doi:10.1128/JVI.01438-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01438-19</ArticleId><ArticleId IdType="pmc">PMC6854495</ArticleId><ArticleId IdType="pubmed">31534043</ArticleId></ArticleIdList></Reference><Reference><Citation>Alirezaei M, Flynn CT, Wood MR, Whitton JL. 2012. Pancreatic acinar cell-specific autophagy disruption reduces coxsackievirus replication and pathogenesis in vivo. Cell Host Microbe 11:298–305. doi:10.1016/j.chom.2012.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.01.014</ArticleId><ArticleId IdType="pmc">PMC3308121</ArticleId><ArticleId IdType="pubmed">22423969</ArticleId></ArticleIdList></Reference><Reference><Citation>Giansanti P, Strating J, Defourny KAY, Cesonyte I, Bottino AMS, Post H, Viktorova EG, Ho VQT, Langereis MA, Belov GA, Nolte-’t Hoen ENM, Heck AJR, van Kuppeveld FJM. 2020. Dynamic remodelling of the human host cell proteome and phosphoproteome upon enterovirus infection. Nat Commun 11:4332. doi:10.1038/s41467-020-18168-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18168-3</ArticleId><ArticleId IdType="pmc">PMC7455705</ArticleId><ArticleId IdType="pubmed">32859902</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yue J. 2020. The interplay of autophagy and enterovirus. Semin Cell Dev Biol 101:12–19. doi:10.1016/j.semcdb.2019.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.08.001</ArticleId><ArticleId IdType="pmc">PMC7102577</ArticleId><ArticleId IdType="pubmed">31563390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita N, Morita E, Itoh T, Tanaka A, Nakaoka M, Osada Y, Umemoto T, Saitoh T, Nakatogawa H, Kobayashi S, Haraguchi T, Guan JL, Iwai K, Tokunaga F, Saito K, Ishibashi K, Akira S, Fukuda M, Noda T, Yoshimori T. 2013. Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J Cell Biol 203:115–128. doi:10.1083/jcb.201304188</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201304188</ArticleId><ArticleId IdType="pmc">PMC3798248</ArticleId><ArticleId IdType="pubmed">24100292</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumati P, Dikic I. 2018. Ubiquitin signaling and autophagy. J Biol Chem 293:5404–5413. doi:10.1074/jbc.TM117.000117</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM117.000117</ArticleId><ArticleId IdType="pmc">PMC5900779</ArticleId><ArticleId IdType="pubmed">29187595</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z, Popelka H, Lei Y, Yang Y, Klionsky DJ. 2020. The roles of ubiquitin in mediating autophagy. Cells 9:2025. doi:10.3390/cells9092025</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9092025</ArticleId><ArticleId IdType="pmc">PMC7564124</ArticleId><ArticleId IdType="pubmed">32887506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai B, Zhao J, Zhang Y, Liu Y, Ma C, Yi F, Zheng Y, Zhang L, Chen T, Liu H, Liu B, Gao C. 2022. USP5 attenuates NLRP3 Inflammasome activation by promoting autophagic degradation of NLRP3. Autophagy 18:990–1004. doi:10.1080/15548627.2021.1965426</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1965426</ArticleId><ArticleId IdType="pmc">PMC9196652</ArticleId><ArticleId IdType="pubmed">34486483</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih C, Liao CC, Chang YS, Wu SY, Chang CS, Liou AT. 2018. Immunocompetent and immunodeficient Mouse models for enterovirus 71 pathogenesis and therapy. Viruses 10:674. doi:10.3390/v10120674</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10120674</ArticleId><ArticleId IdType="pmc">PMC6316343</ArticleId><ArticleId IdType="pubmed">30487421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi MH, Ng LFP. 2017. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front Microbiol 8:2249. doi:10.3389/fmicb.2017.02249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. 2008. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 82:1787–1797. doi:10.1128/JVI.01798-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JKW, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol 86:2121–2131. doi:10.1128/JVI.06103-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ. 2000. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7:523–528. doi:10.1007/BF02253368</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02253368</ArticleId><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Duo J, Liu J, Ma C, Zhang L, Wei Q, Qin C. 2011. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect 13:862–870. doi:10.1016/j.micinf.2011.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.04.004</ArticleId><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. 2012. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12:786–798. doi:10.1038/nri3311</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3311</ArticleId><ArticleId IdType="pmc">PMC3749872</ArticleId><ArticleId IdType="pubmed">23059428</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ. 2000. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. Journal of Clinical Virology 17:23–30. doi:10.1016/S1386-6532(00)00068-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00068-8</ArticleId><ArticleId IdType="pubmed">10814935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Yu CK. 2014. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci 21:31. doi:10.1186/1423-0127-21-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Zuo Y, Qian L, Liu J, Yuan Y, Xu K, Miao Y, Feng Q, Chen X, Jin L, Zhang L, Dong C, Xiong S, Zheng H. 2019. ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP. Nat Microbiol 4:1872–1884. doi:10.1038/s41564-019-0428-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0428-3</ArticleId><ArticleId IdType="pubmed">30988430</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Miao Y, Qian L, Zhang Y, Liu C, Liu J, Zuo Y, Feng Q, Guo T, Zhang L, Chen X, Jin L, Huang F, Zhang H, Zhang W, Li W, Xu G, Zheng H. 2020. Targeting UBE4A revives viperin protein in epithelium to enhance host antiviral defense. Mol Cell 77:734–747. doi:10.1016/j.molcel.2019.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.11.003</ArticleId><ArticleId IdType="pubmed">31812350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HG, Wang B, Yang Y, Liu X, Wang J, Xin N, Li S, Miao Y, Wu Q, Guo T, Yuan Y, Zuo Y, Chen X, Ren T, Dong C, Wang J, Ruan H, Sun M, Xu X, Zheng H. 2022. Depression compromises antiviral innate immunity via the AVP-AHI1-TYK2 axis. Cell Res 32:897–913. doi:10.1038/s41422-022-00689-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00689-9</ArticleId><ArticleId IdType="pmc">PMC9274186</ArticleId><ArticleId IdType="pubmed">35821088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>